NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,276,227 | +1.1% | 81,251 | +0.2% | 1.76% | +8.2% |
| Q2 2023 | $8,185,920 | +9.2% | 81,121 | -0.4% | 1.63% | +5.1% |
| Q1 2023 | $7,496,712 | +9.5% | 81,486 | +8.0% | 1.55% | +9.5% |
| Q4 2022 | $6,847,546 | +20.8% | 75,480 | +1.2% | 1.42% | +11.3% |
| Q3 2022 | $5,669,000 | -9.0% | 74,579 | +1.2% | 1.27% | -3.0% |
| Q2 2022 | $6,228,000 | -1.3% | 73,680 | +2.4% | 1.31% | +7.3% |
| Q1 2022 | $6,313,000 | +4.1% | 71,946 | +3.7% | 1.22% | +7.7% |
| Q4 2021 | $6,067,000 | +11.4% | 69,358 | +4.2% | 1.14% | +2.7% |
| Q3 2021 | $5,444,000 | -2.9% | 66,566 | +8.4% | 1.10% | -10.7% |
| Q2 2021 | $5,604,000 | +13.3% | 61,425 | +6.2% | 1.24% | +1.9% |
| Q1 2021 | $4,946,000 | +0.1% | 57,861 | +10.5% | 1.21% | -12.4% |
| Q4 2020 | $4,943,000 | +18.3% | 52,343 | +8.9% | 1.39% | -3.5% |
| Q3 2020 | $4,180,000 | -0.9% | 48,069 | -0.5% | 1.44% | -6.1% |
| Q2 2020 | $4,219,000 | +1672.7% | 48,302 | +1574.8% | 1.53% | +527.5% |
| Q1 2020 | $238,000 | – | 2,884 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |